158 related articles for article (PubMed ID: 29383315)
1. Methylprednisolone versus Dexamethasone for Control of Vertigo in Patients with Definite Meniere's disease.
Masoumi E; Dabiri S; Khorsandi Ashtiani MT; Erfanian R; Sohrabpour S; Yazdani N; Safaee A; Firouzifar M
Iran J Otorhinolaryngol; 2017 Nov; 29(95):341-346. PubMed ID: 29383315
[TBL] [Abstract][Full Text] [Related]
2. Intratympanic steroid versus gentamicin for treatment of refractory Meniere's disease: A meta-analysis.
Lee SY; Kim YS; Jeong B; Carandang M; Koo JW; Oh SH; Lee JH
Am J Otolaryngol; 2021; 42(6):103086. PubMed ID: 34098455
[TBL] [Abstract][Full Text] [Related]
3. The effect of intratympanic methylprednisolone and gentamicin injection on Ménière's disease.
Gabra N; Saliba I
Otolaryngol Head Neck Surg; 2013 Apr; 148(4):642-7. PubMed ID: 23314159
[TBL] [Abstract][Full Text] [Related]
4. Intratympanic corticosteroids for Ménière's disease.
Webster KE; Lee A; Galbraith K; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Ray J; Van Vugt VA; Westerberg B; Burton MJ
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD015245. PubMed ID: 36847608
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Follow-Up of Intratympanic Methylprednisolone Versus Gentamicin in Patients With Unilateral Menière's Disease.
Harcourt JP; Lambert A; Wong PY; Patel M; Agarwal K; Golding JF; Bronstein AM
Otol Neurotol; 2019 Apr; 40(4):491-496. PubMed ID: 30870364
[TBL] [Abstract][Full Text] [Related]
6. Intratympanic methylprednisolone versus gentamicin in patients with unilateral Ménière's disease: a randomised, double-blind, comparative effectiveness trial.
Patel M; Agarwal K; Arshad Q; Hariri M; Rea P; Seemungal BM; Golding JF; Harcourt JP; Bronstein AM
Lancet; 2016 Dec; 388(10061):2753-2762. PubMed ID: 27865535
[TBL] [Abstract][Full Text] [Related]
7. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
Wu IC; Minor LB
Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial.
Garduño-Anaya MA; Couthino De Toledo H; Hinojosa-González R; Pane-Pianese C; Ríos-Castañeda LC
Otolaryngol Head Neck Surg; 2005 Aug; 133(2):285-94. PubMed ID: 16087029
[TBL] [Abstract][Full Text] [Related]
9. Endolymphatic duct blockage surgery vs. intratympanic steroids for treatment of refractory Ménière's disease.
Saliba I; Dufour-Fournier C; Asmar MH
Eur Arch Otorhinolaryngol; 2024 May; ():. PubMed ID: 38789850
[TBL] [Abstract][Full Text] [Related]
10. Intratympanic mixture gentamicin and dexamethasone versus dexamethasone for unilateral Meniere's disease.
Öztürk K; Ata N
Am J Otolaryngol; 2019; 40(5):711-714. PubMed ID: 31262549
[TBL] [Abstract][Full Text] [Related]
11. Comparing Intratympanic Gentamicin with Methylprednisolone in Meniere's Disease with Non-Serviceable Hearing.
Thomas L; Lepcha A; Reka K; Augustine AM; Alex A; Philip A; Mammen MD
Indian J Otolaryngol Head Neck Surg; 2022 Dec; 74(Suppl 3):3738-3745. PubMed ID: 36742746
[TBL] [Abstract][Full Text] [Related]
12. Intratympanic Dexamethasone in the Treatment of Ménière's Disease: A Comparison of Two Techniques.
Beyea JA; Instrum RS; Agrawal SK; Parnes LS
Otol Neurotol; 2017 Jul; 38(6):e173-e178. PubMed ID: 28437363
[TBL] [Abstract][Full Text] [Related]
13. Control of vertigo after intratympanic corticoid therapy for unilateral Ménière's disease: a comparison of weekly versus daily fixed protocols.
Martin Sanz E; Zschaeck C; Gonzalez M; Mato T; Rodrigañez L; Barona R; Sanz R
Otol Neurotol; 2013 Oct; 34(8):1429-33. PubMed ID: 23722456
[TBL] [Abstract][Full Text] [Related]
14. Response Over Time of Vertigo Spells to Intratympanic Dexamethasone Treatment in Meniere's Disease Patients.
Atrache Al Attrache N; Krstulovic C; Pérez Guillen V; Morera Pérez C; Pérez Garrigues H
J Int Adv Otol; 2016 Apr; 12(1):92-7. PubMed ID: 27340991
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Effect of Intratympanic Injection of Dexamethasone plus Hyaluronic Acid on Patients with Meniere's disease.
Rogha M; Abtahi H; Asadpour L; Ghazavi H; Pourmohammadi R; Maleki M; Ghadimi K
Iran J Otorhinolaryngol; 2019 Jul; 31(105):217-223. PubMed ID: 31384587
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of intratympanic methylprednisolone perfusion treatment on intractable Ménière's disease.
She W; Lv L; Du X; Li H; Dai Y; Lu L; Ma X; Chen F
J Laryngol Otol; 2015 Mar; 129(3):232-7. PubMed ID: 25655232
[TBL] [Abstract][Full Text] [Related]
17. Control of vertigo in Ménière's disease by intratympanic dexamethasone.
Weckel A; Marx M; Esteve-Fraysse MJ
Eur Ann Otorhinolaryngol Head Neck Dis; 2018 Feb; 135(1):7-10. PubMed ID: 28760618
[TBL] [Abstract][Full Text] [Related]
18. Intratympanic steroids for Ménière's disease or syndrome.
Phillips JS; Westerberg B
Cochrane Database Syst Rev; 2011 Jul; (7):CD008514. PubMed ID: 21735432
[TBL] [Abstract][Full Text] [Related]
19. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
Silverstein H; Wazen J; Van Ess MJ; Daugherty J; Alameda YA
Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280
[TBL] [Abstract][Full Text] [Related]
20. Intratympanic dexamethasone and hyaluronic acid in patients with low-frequency and Ménière's-associated sudden sensorineural hearing loss.
Selivanova OA; Gouveris H; Victor A; Amedee RG; Mann W
Otol Neurotol; 2005 Sep; 26(5):890-5. PubMed ID: 16151334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
